Immucell (ICCC) Net Margin (2009 - 2026)
Immucell (ICCC) recorded Net Margin of 11.85% in Q3 2026, up 14.39 percentage points from -2.54% a year earlier but down 13.68 percentage points from the prior quarter.
Immucell (ICCC) Net Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Immucell's Net Margin came in at 5.66% as of Sep 30, 2026, down 2.71 percentage points year-over-year; for FY2025, it was -3.76%, up 4.38 percentage points from FY2024.
- Annual Net Margin has a five-year change of +2.90 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at -8.14% in FY2024 (+24.91 pp), -33.05% in FY2023 (-19.62 pp), -13.43% in FY2022 (-13.02 pp) and -0.41% in FY2021 (+6.26 pp).
- Quarterly Net Margin has ranged from -67.17% in Q1 2023 to 25.53% in Q2 2026 over the past five years.
- On a year-over-year basis, Net Margin has increased for three consecutive quarters, with an average year-over-year change of +8.26 percentage points over the last seven quarters.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 61.14 percentage points in Q1 2024, against a drop of 84.28 percentage points in Q1 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 25.53% (Q2 2026), 18.75% (Q1 2026) and -37.36% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 19.55% |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | 11.85% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.85% |
| Jun 30, 2026 | 25.53% |
| Mar 31, 2026 | 18.75% |
| Dec 31, 2025 | -37.36% |
| Sep 30, 2025 | -2.54% |
| Jun 30, 2025 | 7.79% |
| Mar 31, 2025 | 17.94% |
| Dec 31, 2024 | 6.64% |
| Sep 30, 2024 | -11.67% |
| Jun 30, 2024 | -27.99% |
| Mar 31, 2024 | -6.03% |
| Sep 30, 2023 | -17.42% |
| Jun 30, 2023 | -39.06% |
| Mar 31, 2023 | -67.17% |
| Dec 31, 2022 | -42.65% |
| Sep 30, 2022 | -13.66% |
| Jun 30, 2022 | -35.44% |
| Mar 31, 2022 | 17.11% |
| Dec 31, 2021 | 1.36% |
| Sep 30, 2021 | 2.87% |
Immucell Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();